WASHINGTON (AP) — The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week, setting up shots for many before the beginning of the next school year.

That's according to a federal official and a person familiar with the process.

The FDA action would be followed by a meeting of a federal vaccine advisory committee to discuss whether to recommend the shot for 12- to 15-year-olds.

Then the Centers for Disease Control and Prevention would act on the committee’s recommendation. Those steps could be completed in a matter of days.

Receive the top KOMU 8 News headlines of the day in your inbox.
START YOUR DAY INFORMED

Brought to you by First Midwest Bank

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.